Phase I clinical trials represent a major milestone in a new medical product’s journey from lab to market. The insights gathered from testing a product on humans is key to determining its viability as a treatment option and sets the tone for the whole research process. When early phase studies experience issues with site selection, recruitment, patient safety, and inefficient trial processes, it can result in costly delays to FDA submission and market arrival. Sponsors, CROs, and study managers need a flexible, unified eClinical suite to sprint their Phase 1 studies and ensure success all the way to final market approval.
Success in early phase trials can lay the foundation for subsequent phases. Our flexible, integrated solutions were designed to reduce inefficiencies that result in lengthy and costly delays to sponsors. Build, test, and deploy your study in days, not months, with our intuitive point-and-click interface. Watch timelines continue to shorten as you leverage our extensive library of reusable and customizable forms.
Drag-and-drop workflows remove the need for timely training or programming support so you can build eCRFs and study protocols with efficiency, speed, and control.
Early-stage studies have unique characteristics, but many follow similar designs. Access our library of customizable forms and templates or copy databases from previous studies to reuse, reconfigure, and reduce build timelines.
eLearning videos for site staff, event- and subject-based navigation, and intuitive technology make it quick and easy to roll out study protocol to sites with minimal need for training.
The clinic team loved using the tablets for mobile data capture during that first study. They loved having to sign in only once and then being able to simply click and save a result without having to sign their name and enter a date over and over. They also loved not having to initial and supply a reason for every update or
Rapidly progressing through early phase trials shouldn’t be at the expense of your data quality and accuracy. Our unified eSuite offers real-time, event-driven data collection to power informed decisions about your study and detect safety signals that protect patient safety.
Mid-study changes are commonplace in Phase I studies, and researchers need an efficient way to handle them without system downtime. Medrio makes it possible to review and deploy changes safely from a test environment to the live study in a matter of clicks without vendor reliance, downtime, pesky database migrations, or hidden fees.
Our straightforward, transparent pricing model is ideal for fast-moving Phase I studies.
Medrio empowers sponsors and CROs across all phases of clinical research to accelerate their processes and reduce costs. But it’s our Phase I users who truly see the benefits of getting a strong eClinical start as a product begins its journey to market.